Ȩ > ±Û·Î¹úÆÄÆ®³Ê > La Merie Publishing

La Merie Publishing

±Û·Î¹úÀÎÆ÷¸ÞÀ̼ÇÀº La Merie PublishingÀÇ Çѱ¹ ÆÄÆ®³ÊÀÔ´Ï´Ù. La Merie Publishing°¡ ¹ßÇàÇÏ´Â ½ÃÀå º¸°í¼­¸¦ ÆǸÅÇÏ°í ÀÖ½À´Ï´Ù. °Ë»öµÇÁö ¾Ê´Â ÀÚ·áµµ ÁÖ¹® °¡´ÉÇÏ´Ï ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
½ºÆäÀÎ ¹Ù¸£¼¿·Î³ª¿¡ º»»ç¸¦ µÐ La Merie´Â ¹ÙÀÌ¿À Å×Å©³î·¯Áö ¹× Á¦¾à »ê¾÷¿¡ ´ëÇÑ ¸®¼­Ä¡¸¦ Àü¹®À¸·Î ÇÏ°í ÀÖ½À´Ï´Ù.
°Ë»ö
Á¦¸ñ°Ë»ö
1 - 5 ¸®ºä (Àüü£º 5 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective
¸®¼­Ä¡»ç
La Merie Publishing
»óÇ°ÄÚµå
1548965
¹ßÇàÀÏ
2024³â 09¿ù
ÆäÀÌÁö Á¤º¸
174 Pages
°¡°Ý
EUR 2,050 -> £Ü 3,110,000 (ºÎ°¡¼¼ º°µµ)
¿­¶÷ ¼­ºñ½º
Report Package: Claudin 18.2-Targeted Immunotherapeutics
¸®¼­Ä¡»ç
La Merie Publishing
»óÇ°ÄÚµå
1477527
¹ßÇàÀÏ
2024³â 04¿ù
ÆäÀÌÁö Á¤º¸
314 Pages
°¡°Ý
EUR 2,150 -> £Ü 3,262,000 (ºÎ°¡¼¼ º°µµ)
¿­¶÷ ¼­ºñ½º
Claudin 18.2 - Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from an Industry Perspective
¸®¼­Ä¡»ç
La Merie Publishing
»óÇ°ÄÚµå
1328018
¹ßÇàÀÏ
2023³â 08¿ù
ÆäÀÌÁö Á¤º¸
267 Pages
°¡°Ý
EUR 2,150 -> £Ü 3,262,000 (ºÎ°¡¼¼ º°µµ)
¿­¶÷ ¼­ºñ½º
¸®¼­Ä¡»ç
La Merie Publishing
»óÇ°ÄÚµå
1262973
¹ßÇàÁ¤º¸
¿¬°£±¸µ¶
ÆäÀÌÁö Á¤º¸
 
°¡°Ý
EUR 1,600 -> £Ü 2,427,000 (ºÎ°¡¼¼ º°µµ)
CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing
¸®¼­Ä¡»ç
La Merie Publishing
»óÇ°ÄÚµå
1213672
¹ßÇàÀÏ
2023³â 02¿ù
ÆäÀÌÁö Á¤º¸
96 Pages
°¡°Ý
EUR 1,800 -> £Ü 2,730,000 (ºÎ°¡¼¼ º°µµ)
¿­¶÷ ¼­ºñ½º
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦